Approach to Menstrual-Related Headache in a 38-Year-Old Woman
For a 38-year-old woman with headaches starting at menses, first confirm this is menstrual migraine through a 3-month headache diary documenting attacks occurring from 2 days before through day 3 of menstruation, then treat acute attacks with combination therapy (triptan + NSAID), and if attacks persist or are severe, initiate perimenstrual prophylaxis with frovatriptan 2.5 mg twice daily or naproxen starting 2 days before expected menses for 5 days. 1, 2
Step 1: Establish the Diagnosis
Document the Pattern
- Have the patient maintain a 3-month headache diary to confirm the temporal relationship between headaches and menstruation 3, 1
- Menstrual migraine is defined as attacks occurring predictably from 2 days before menstruation through the first 3 days of bleeding 1, 4
- Approximately 8% of women have pure menstrual migraine (attacks exclusively during menstruation), while others have menstrually-related migraine with additional attacks at other times 1
Key History Elements to Obtain
Ask specifically about 3:
- Character of pain: throbbing, unilateral location
- Associated symptoms: nausea, vomiting, photophobia, phonophobia
- Presence or absence of aura (visual disturbances, sensory changes)
- Duration: typically hours to days
- Severity and functional disability: menstrual attacks are characteristically more severe, longer-lasting, and more disabling than non-menstrual attacks 4, 5
- Response to prior treatments: over-the-counter medications, prescription drugs
- Family history of migraine
- Other menstrual symptoms: dysmenorrhea, menorrhagia, irregular cycles
Rule Out Red Flags
Do NOT perform neuroimaging unless red flags are present 3:
- Rapidly increasing headache frequency
- Focal neurologic signs or symptoms
- Headache awakening patient from sleep
- Thunderclap onset
- Marked change in headache pattern
- Persistent headache after head trauma
- Atypical features inconsistent with migraine
Important caveat: Not all menstruation-associated headaches are migraine. Consider paroxysmal hemicrania if attacks are very short (5-20 minutes), occur multiple times daily, and have prominent autonomic features (tearing, nasal congestion, restlessness) 6
Step 2: Acute Treatment Strategy
First-Line Acute Therapy
Start with combination therapy for moderate-to-severe attacks 2:
- Triptan + NSAID (e.g., sumatriptan 50-100 mg + naproxen 500 mg)
- This combination is superior to either agent alone
- Counsel patient to take medication as early as possible after headache onset to maximize efficacy 2
Alternative Acute Options
For mild attacks 2:
- NSAID alone (ibuprofen, naproxen, diclofenac)
- Acetaminophen (less effective than NSAIDs)
- NSAID + acetaminophen combination
If combination therapy fails 2:
- Try different triptans (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, zolmitriptan) - patients may respond to one triptan but not another
- Consider CGRP antagonists (rimegepant, ubrogepant, zavegepant)
- Non-oral triptan (sumatriptan subcutaneous) if severe nausea/vomiting present 2
Critical Warnings
- NEVER use opioids or butalbital for migraine treatment 2
- Monitor for medication overuse headache: ≥10 days/month triptan use or ≥15 days/month NSAID use can cause rebound headaches 2, 3
Step 3: Perimenstrual Prophylaxis (If Acute Treatment Insufficient)
Menstrual attacks are notoriously more severe and treatment-resistant than non-menstrual attacks 7, 4, 5. The predictable timing allows for targeted short-term prevention.
Evidence-Based Perimenstrual Prophylaxis Options
Initiate prophylaxis 2 days before expected menstruation and continue for 5 days 1:
First choice - Triptans (Grade B evidence) 1, 4:
- Frovatriptan 2.5 mg twice daily
- Naratriptan 1 mg twice daily
- These long-acting triptans have proven efficacy for perimenstrual prophylaxis
Alternative - NSAIDs 1:
- Naproxen 500 mg twice daily (or other long-acting NSAID)
- Particularly useful if patient has comorbid dysmenorrhea 7
- Allows use of triptans for breakthrough headaches
When to Consider Long-Term Prevention
If patient has 3:
- More than 2 headaches per week (including non-menstrual attacks)
- Frequent episodic migraine requiring preventive medication
- Inadequate response to perimenstrual prophylaxis
Long-term preventive options 1, 8:
- First-line: Propranolol, metoprolol, topiramate, candesartan
- Second-line: Amitriptyline, flunarizine
- Third-line: CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab), onabotulinumtoxinA
Step 4: Hormonal Strategies (For Women Needing Contraception)
Combined Hormonal Contraceptives
For women with pure menstrual migraine WITHOUT aura 1:
- Consider continuous or extended-cycle combined hormonal contraceptives (no hormone-free interval)
- This eliminates the estrogen withdrawal that triggers menstrual migraine
- Treats comorbid conditions: dysmenorrhea, menorrhagia, endometriosis, irregular cycles 7
Critical Contraindication
Combined hormonal contraceptives are ABSOLUTELY CONTRAINDICATED in women with migraine with aura due to increased stroke risk 1
Alternative Hormonal Approach
- Transdermal estradiol 1.5 mg applied perimenstrually (Grade B evidence) 4
- Prevents the premenstrual estrogen decline that precipitates attacks
Step 5: Lifestyle Modifications and Patient Education
Essential Counseling Points 2
- Hydration: maintain adequate fluid intake
- Regular meals: avoid skipping meals
- Sleep hygiene: consistent sleep schedule, 7-8 hours nightly
- Regular aerobic exercise: moderate to intense physical activity
- Stress management: relaxation techniques, mindfulness
- Weight management if overweight/obese
Set Realistic Expectations 1
- Migraine is not curable but is controllable
- Goal is to reduce attack frequency, severity, and duration to minimize disability
- Treatment success means regaining control from the disease, not complete elimination of all headaches
Step 6: Follow-Up and Monitoring
- Reassess in 2-3 months after initiating or changing treatment 1
- Continue headache diary to track:
- Attack frequency (migraine days per month)
- Attack severity and duration
- Functional disability
- Acute medication use (to monitor for overuse)
- Adjust treatment based on response
When Treatment Fails
- Verify diagnosis is correct
- Confirm medication adherence and proper use
- Check for medication overuse headache
- Consider switching within drug class (different triptan, different NSAID)
- Escalate to next treatment tier
Special Considerations for This 38-Year-Old Patient
Reproductive Planning
- If pregnancy is planned or possible, discuss medication safety 2, 8
- Migraine often improves during pregnancy, especially after first trimester
- Safest acute options in pregnancy: acetaminophen, limited triptan use (emerging evidence suggests may be safer than previously thought) 5
- Avoid topiramate and valproate in women of childbearing potential (teratogenic) 1, 8
Age-Appropriate Counseling
- At 38, patient is in peak years for menstrual migraine prevalence
- After age 45, the gender difference in migraine prevalence decreases 9
- Perimenopausal transition may alter migraine patterns in coming years
This algorithmic approach prioritizes the most recent high-quality guidelines 1, 2 while incorporating specific evidence for menstrual migraine management 4. The stepped approach ensures appropriate escalation from acute treatment to prophylaxis based on treatment response and attack severity.